Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma

Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma

Abstract Background Gastric cardia adenocarcinoma (GCA) is classified as Siewert type II adenocarcinoma at the esophagogastric junction in Western countries. The majority of GCA patients do not exhibit early warning symptoms, leading to over 90% of diagnoses at an advanced stage, resulting in a grim...

Full description

Bibliographic Details
Main Authors: Meng Xia Wei, Zheng Yang, Pan Pan Wang, Xue Ke Zhao, Xin Song, Rui Hua Xu, Jing Feng Hu, Kan Zhong, Ling Ling Lei, Wen Li Han, Miao Miao Yang, Fu You Zhou, Xue Na Han, Zong Min Fan, Jia Li, Ran Wang, Bei Li, Li Dong Wang
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Cancer Medicine
Subjects:
bile acid
gastric cardia adenocarcinoma
HER2
metabolomics
stage
Online Access:https://doi.org/10.1002/cam4.7015

Internet

https://doi.org/10.1002/cam4.7015

Similar Items